NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/23/2019
Back to search
Official data from USPTO
MOFFITT CANCER CENTER M
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000076687026Class
16, 41, 42, 44
Filing
76687026
Registration
3671302
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
05/13/2025
Trademark type
Combined
Nice classes
16, 41, 42, 44
Filing date
02/22/2008
Registration date
08/25/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/23/2019
Last transaction
05/13/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
11/30/2007
First use in commerce
11/30/2007
Drawing code
3
Owner type
03
Owner location
Tampa, FL
Examiner
BUJA, SANDRA
Law office
L40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
H. Lee Moffitt Cancer Center and Research Institute, Inc.
Representatives
Corey K. Cho Saliwanchik, Lloyd & Eisenschenk, P.A.
Technical classification
Nice Classes
Class 16Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Publicationsprinted instructional and teaching materialsbrochurespamphletsbulletinsnewsletters and magazinesall in the field of health carecancer protectionpreventiondetection and treatmentmedical diagnostics and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases
Class 41
Medical educational servicesconducting lecturesseminars and workshops to health care practitionerspatients and patient caregivers in the field of health carecancer care and prevention of cancermedical diagnosticsprognostics and the evaluation of drug and treatment effectiveness relating to cancer and other diseases
Class 42
Providing an online database and depository for the collection of clinical and molecular data derived from a patient that is accessible by physicianspatients and researchersan online database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases for research purposes; medical and clinical research resources in the field of cancer and other diseasesproviding data regarding tumor-specific molecular signatures and the effectiveness of a drug and/or diagnostic test for research purposes; medical and clinical research resources in the field of cancer and other diseasesproviding evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes for research purposes; medical research services consisting of collection and analysis of data in the field of human clinical and molecular data for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseasesmatching particular patients to a particular drugtreatmenttherapy or clinical trial by the specific molecular signature of the patient; collection and analysis of data services in the field of human clinical and molecular data accumulation and analysis for research assistance for medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseasesproviding objective data in usable form on the effectiveness of a drug or diagnostic test
Class 44
Providing health caremedical information and counseling in the field of cancer; providing medical screening and diagnostic services with use of patient scanning equipment; providing an online computer database featuring medical information in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnosticsprognostics and the evaluation and testing of drug and treatment effectiveness; medical servicescancer care and prevention of cancermedical diagnosticsprognostics and evaluation of drug and treatment effectiveness relating to cancer and other diseases; medical counseling; telephone hot line counselingoffering advice regarding cancer preventiondetectiontreatment and clinical testing in the field of cancer and other diseases
Publications
History of USPTO decisions and trademark events.
43 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/23/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/23/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/20/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
03/07/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/25/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/23/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/22/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/22/2014
E815
TEAS SECTION 8 & 15 RECEIVED
12/03/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/28/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
08/25/2009
PUBO
PUBLISHED FOR OPPOSITION
06/09/2009
NPUB
NOTICE OF PUBLICATION
05/20/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/05/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/29/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
04/29/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/29/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
04/29/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/29/2009
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/28/2009
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/13/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/01/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/26/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/12/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/11/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/18/2009
GNRT
NON-FINAL ACTION E-MAILED
02/18/2009
CNRT
NON-FINAL ACTION WRITTEN
02/18/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/26/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/26/2009
ALIE
ASSIGNED TO LIE
01/22/2009
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/17/2008
ALIE
ASSIGNED TO LIE
12/17/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/08/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/08/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2008
CNRT
NON-FINAL ACTION MAILED
06/16/2008
CNRT
NON-FINAL ACTION WRITTEN
06/14/2008
DOCK
ASSIGNED TO EXAMINER
06/04/2008
MAFR
APPLICATION FILING RECEIPT MAILED
03/04/2008
NWAP
NEW APPLICATION ENTERED
02/28/2008
Continuous trademark protection
Get notified about every new filing that threatens MOFFITT CANCER CENTER M or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.